4 completed. 4 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 4 |
Follow itepekimab: new trials by email Literature Review of itepekimab trials Research Report on itepekimab
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pharmacokinetic Study to Compare Itepekimab Exposure When Administered With an Autoinjector Versus Prefilled Syringe Itepekimab AI, Itepekimab PFS - Chronic Obstructive Pulmonary Disease | Phase 1 | Completed | Sanofi | 90 | 2021-09-16 | 2024-09-19 |
| Study of REGN3500 and Dupilumab in Patients With Asthma REGN3500, Dupilumab, Placebo - Asthma, Allergic | Phase 1 | Completed | Regeneron Pharmaceuticals | 32 | 2017-06-15 | 2020-01-18 |
| Study of Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of REGN3500 in Adults With Moderate Asthma REGN3500, Placebo - Asthma, Moderate Asthma | Phase 1 | Completed | Regeneron Pharmaceuticals | 23 | 2017-02-03 | 2018-12-12 |
| A Study of Intravenously or Subcutaneously Administered REGN3500 in Healthy Adult Subjects REGN3500, Placebo - Healthy Volunteers | Phase 1 | Completed | Regeneron Pharmaceuticals | 40 | 2016-08-01 | 2017-11-08 |
Asthma (2) · Pulmonary Disease, Chronic Obstructive (1)
Regeneron Pharmaceuticals (3) · Sanofi (1)
United Kingdom (2) · United States (2) · Belgium (1)
2016 (3)